Chemoinformaics analysis of (2S)-2-(DIAMINOMETHYLIDENEAMINO)BUTANEDIOIC ACID
| Molecular Weight | 175.144 | nRot | 4 |
| Heavy Atom Molecular Weight | 166.072 | nRig | 15 |
| Exact Molecular Weight | 175.059 | nRing | 0 |
| Solubility: LogS | -2.591 | nHRing | 0 |
| Solubility: LogP | 2.481 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 9 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 20.8591 |
| nHD | 4 | BPOL | 10.7649 |
| QED | 0.549 |
| Synth | 1.888 |
| Natural Product Likeliness | -0.131 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.008 |
| HIA | 0.008 |
| CACO-2 | -4.585 |
| MDCK | 0.000027 |
| BBB | 0.966 |
| PPB | 0.87491 |
| VDSS | 1.976 |
| FU | 0.110385 |
| CYP1A2-inh | 0.995 |
| CYP1A2-sub | 0.662 |
| CYP2c19-inh | 0.795 |
| CYP2c19-sub | 0.323 |
| CYP2c9-inh | 0.268 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.875 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.906 |
| CYP3a4-sub | 0.338 |
| CL | 8.574 |
| T12 | 0.666 |
| hERG | 0.051 |
| Ames | 0.497 |
| ROA | 0.963 |
| SkinSen | 0.908 |
| Carcinogencity | 0.116 |
| EI | 0.991 |
| Respiratory | 0.99 |
| NR-Aromatase | 0.881 |
| Antiviral | No |
| Prediction | 0.885872 |